Hyperammonemic encephalopathy

Medicine

Volumn 81, Issue 3, 2002, Pages 240-249

  Brusilow, Saul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMINE; INOSITOL; METHIONINE SULFOXIMINE;

ASTROCYTE; BRAIN DISEASE; BRAIN EDEMA; DRUG ACTIVITY; DRUG INDICATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; LIVER FAILURE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; REVIEW; UREA CYCLE;

ADOLESCENT; ANIMALS; ASTROCYTES; BRAIN DISEASES, METABOLIC; FATAL OUTCOME; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; LIVER FAILURE; METHIONINE SULFOXIMINE; ORNITHINE CARBAMOYLTRANSFERASE;

EID: 0036256827     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200205000-00007     Document Type: Review

References (76)

1. Quantitative tests of nitrogen metabolism in cirrhosis: Relation to other manifestations of liver disease
2. Changes in brain metabolism during hyperammonemia and acute liver failure: Results of a comparative 1H-NMR spectroscopy and biochemical, investigation
3. Inborn errors of ureagenesis
4. Urea cycle enzymes
5. Urea cycle disorders: Diagnosis, pathophysiology, therapy
6. Letter to the editor
7. Type II Alzheimer change experimentally produced in astrocytes in the rat
8. Localized proton MR spectroscopy in infants with urea cycle defect
9. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration
10. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency
11. Cerebral glutamine synthesis
12. Increased intracranial pressure and hepatic encephalopathy in chronic liver disease
13. Regulation of glutaminase activity and glutamine metabolism
14. Idiopathic hyperammonemia: A frequently lethal complication of bone marrow transplantation
15. Deaths and hospitalizations from chronic liver disease and cirrhosis United States, 1980 - 1989
16. Cerebral oedema and increased intracranial pressure in chronic liver disease
17. Studies on the metabolism of amino acids and related compounds in vivo. VI. Free amino acid levels in the tissues of rats protected against ammonemia toxicity
18. Hyperammonemia encephalopathy related to ureterosigmoidostomy
19. Hepatic encephalopathy
20. Late-onset ornithine transcarbamylase deficiency in male patients
21. Free glutamine level in the rat brain in vivo after methionine sulphoximine administration
22. The relative effect of methionine sulfoximine on different animal species
23. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure
24. Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy
25. Glial cell function: Active control of extracellular K+ concentration
26. L-Methionine DL-sulphoximine and acute ammonia toxity
27. Impaired pial arteriolar reactivity to hypercapnia during hyperammonemia depends on glutamine synthesis
28. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy
29. Effect of ammonia and methionine sulfoximine on myo-inositol transport in cultured astrocytes
30. Methionine sulfoximine prevents the accumulation of large neutral amino acids in brain of hyperammonemic rats
31. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure
32. Astrocytes
33. Effect of methionine sulfoximine in man
34. The duration of the inhibition of glutamine synthetase by methionine sulfoximine
35. Morphometric studies of rat glial ultrastructure after urease-induced hyperammonemia
36. Amino acid changes in autopsied brain tissues from cirrhotic patients with hepatic encephalopathy
37. Hyperammonemia: A deficiency of ornithine transcarbamylase
38. Fatal hyperammonemia after orthotopic lung transplantation
39. Long-term treatment of girls with ornithine transcarbamylase deficiency
40. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis
41. Energy on demand
42. Electron microscopy in human hepatic encephalopathy
43. Glutamine synthetase: Glial localization in brain
44. Regulation of cell volume in health and disease
45. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: Review of nine cases
46. Astrocytes: Form, functions and roles in disease
47. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy nonencephalopathic patients with cirrhosis. A controlled study
48. Neurologic outcome in children with inborn errors of urea synthesis
49. Hemodialysis for inborn errors of metabolism
50. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy
51. Astroglial dysfunction in hepatic encephalopathy
52. Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines
53. Fine structural localization of glutamine synthetase in astrocytes of rat brain
54. Blood-ammonium levels in liver disease and "hepatic coma"
55. Valproic acid and secondary hyperammonemia
56. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy
57. Acid-base and metabolic disturbances in fulminant hepatic failure
58. Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine
59. Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis
60. Methionine sulfoximine seizures. VIII. The dissociation of the convulsant and glutamine synthetase inhibitory effects
61. Hyperammonaemic encephalopathy in chronic myelomonocytic leukaemia
62. Studies of the blood ammonia in liver disease: Its diagnostic, prognostic and therapeutic significance
63. Methionme sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia
64. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats
65. Control of synapse number by glia
66. Respiratory alkalosis in hepatic coma
67. Acute hyperammonemia in the young primate: Physiologic and neuropathologic correlates
68. Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism
69. Transient idiopathic hyperammonemia in adults
70. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat
71. Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography
72. Ultrastructural pathology in congenital defects of the urea cycle: Ornithine transcarbamylase and carbamylphosphate synthetase deficiency
73. Multinuclear NMR spectroscopy studies on NH4Cl-induced metabolic alterations and detoxification processes in primary astrocytes and glioma cells